Cough Clinical Trial
Official title:
Validation of Peptest™ for the Detection of Reflux in Cough; Induction of Cough in Healthy Volunteers
NCT number | NCT03851393 |
Other study ID # | Acadmed130514 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 2014 |
Est. completion date | October 2014 |
Verified date | July 2019 |
Source | Hull and East Yorkshire Hospitals NHS Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic cough is a common presenting problem which has a significant impact on quality of
life. Gastro-oesophageal reflux (GOR) is a common cause of chronic cough and reflux of
stomach contents into the airways has been implicated in the pathogenesis of a number of
respiratory diseases. Clinical history in patients with suspected reflux can aid in the
diagnosis but traditional investigations for GOR including 24hr oesophageal pH monitoring or
endoscopy are not reliable diagnostic tools since the reflux may be non acidic.
The detection of pepsin in the sputum, saliva or bronchial biopsy has been found to be an
accurate marker of reflux into the airways. Pepsin is solely produced by parietal cells in
the stomach. The presence of pepsin in the upper airways therefore indicates reflux. Studies
have demonstrated that pepsin was frequently found in laryngeal biopsies and sputum of
patients with signs and symptoms of airways reflux and that Nissen fundoplication resulted in
a decrease in pepsin detection alongside an improvement in symptoms. The Peptest™ lateral
flow device has been shown to be effective in the detection of pepsin in sputum and saliva of
patients with chronic cough and gastro-oesophageal reflux. The investigators have detected
pepsin in expectorated saliva during episodes of cough, apparently supporting a diagnosis of
airways reflux. Critics, however, have suggested that the act coughing itself is responsible
for the reflux.
This study aims to identify if cough induced by inhaled citric acid in healthy adult
volunteers leads to detectable pepsin in expectorated saliva.
Status | Completed |
Enrollment | 30 |
Est. completion date | October 2014 |
Est. primary completion date | October 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - A negative score for airway reflux (HARQ score <13). - Provision of informed consent. Exclusion Criteria: - Participants with a positive score for airway reflux (HARQ score >13). - Chronic respiratory disease. - Acute gastro-respiratory illness at the time of the study. - Participants who will be physically unable to undergo sputum collection or cough induction. - Those who are unwilling to undergo cough challenge and induction of cough. - Smoking or consumption of food, caffeinated or carbonated beverages for 30 minutes prior to sample collection. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Hull Clinical Trials Unit, Respiratory academic department | Cottingham | Yorkshire |
Lead Sponsor | Collaborator |
---|---|
Hull and East Yorkshire Hospitals NHS Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | level of pepsin in saliva following a citric acid cough challenge | detecting the levels of pepsin in saliva following Citric acid induced cough | 3 months | |
Secondary | normal range of saliva pepsin | record normal range of saliva pepsin following citric acid cough challenge | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00116337 -
Spinal Cord Stimulation to Restore Cough
|
N/A | |
Not yet recruiting |
NCT04064333 -
Slow-Stream Expiratory Muscle Strength Training for Veterans With Dysphagia Living in Long-term Care
|
N/A | |
Recruiting |
NCT02482818 -
Efficacy of Pregabalin on Chronic Cough
|
Phase 1/Phase 2 | |
Terminated |
NCT02269761 -
Chest Ultrasound of ER Patients With Cough or SOB
|
||
Active, not recruiting |
NCT02065440 -
The Effect of Ebastine/Pseudoephedrine on Subacute Cough
|
N/A | |
Completed |
NCT01071161 -
The Effect of Azithromycin in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Productive Cough
|
Phase 3 | |
Completed |
NCT00353951 -
An Observational Study of Cough / Lower Respiratory Tract Infection (LRTI) in Primary Care
|
N/A | |
Terminated |
NCT00668317 -
Bronchial Hyper-responsiveness in Reflux Cough
|
Phase 3 | |
Completed |
NCT00127686 -
Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep
|
Phase 1 | |
Completed |
NCT00287339 -
The Utility of Nexium in Chronic Cough and Reflux Disease
|
Phase 4 | |
Recruiting |
NCT05115097 -
AI Evaluation of COVID-19 Sounds (AI-EChOS)
|
||
Recruiting |
NCT04457011 -
Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children
|
Phase 2 | |
Recruiting |
NCT05042063 -
Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease
|
||
Recruiting |
NCT03922373 -
A Study of Benzonatate Soft Capsule in Chinese Healthy Subjects
|
Phase 1 | |
Completed |
NCT05812209 -
Stellate Ganglion Block to Treat Long COVID 19 Case Series
|
||
Recruiting |
NCT04767074 -
A Non-pharmacological Cough Control Therapy
|
N/A | |
Recruiting |
NCT05570539 -
Assessment of the Pharmacokinetics of BLU-5937 Extended Release Prototypes and a BLU-5937 Immediate Release Reference Formulation
|
Phase 1 | |
Completed |
NCT03999203 -
A Cross-sectional Study to Measure Cough in Severe Asthma
|
N/A | |
Active, not recruiting |
NCT05479929 -
Work of Breathing Assessment in Triage Scale
|
||
Recruiting |
NCT02495571 -
Assessment of Voluntary and Reflex Cough in Patients With ALS
|
N/A |